RYM.AX ASX
Ryman Healthcare Ltd.
1W: -6.4%
1M: -12.5%
3M: -20.1%
YTD: -37.2%
A$1.47 ($1.02)
-0.01 (-0.34%)
Weekly Expected Move ±6.9%
A$1
A$1
A$1
A$2
A$2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$714M
+9.7% ▲
3Y CAGR: +12.3%
Gross Profit
$714M
+9.7% ▲
3Y CAGR: +12.3%
Operating Income
-$118M
-69.9% ▼
Net Income
-$437M
-9248.3% ▼
EPS (Diluted)
$-0.60
-100.0% ▼
EBITDA
-$27M
+46.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Revenue | $504M | $560M | $651M | $714M |
| YoY Growth | +0.0% | +11.2% | +16.1% | +9.7% |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $504M | $560M | $651M | $714M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $306M | $0 | $464M | $544M |
| Operating Expenses | $502M | $580M | $720M | $832M |
| Operating Income | $2M | -$20M | -$70M | -$118M |
| Operating Margin | 0.4% | -3.5% | -10.7% | -16.6% |
| Interest Expense | $31M | $205M | $50M | $140M |
| Income Before Tax | $722M | $206M | -$145M | -$215M |
| Tax Expense | $29M | -$52M | -$150M | $221M |
| Net Income | $693M | $258M | $5M | -$437M |
| Net Margin | 137.5% | 46.0% | 0.7% | -61.2% |
| EPS (Diluted) | $1.23 | $0.47 | $0.01 | $-0.60 |
| EBITDA | $788M | $458M | -$51M | -$27M |
| Shares Outstanding | 563M | 548M | 730M | 730M |